ADVERTISEMENT
News
Antihistamine Recalled
12/10/2020
The recall affects 30-count bottles of levocetirizine dihydrochloride tablets, 5 mg (NDC 10135-0639-30), from lots 051944A (Exp. 4/21), 1119124 (Exp. 10/21), and 062088 (Exp. 6/22).
InvaTech Pharma Solutions voluntarily initiated the recall November 11, 2020. The FDA designated the recall Class III on December 3, 2020. Under the recall classification, use of the affected tablets is not likely to cause harm.
Levocetirizine dihydrochloride is a prescription antihistamine used to treat hay fever and hives.
—Jolynn Tumolo